From the Department of Orthopaedic Surgery, University of California Davis School of Medicine, Sacramento, CA (Le, Javidan, Khan), and the Department of Orthopaedic Surgery, John P. and Kathrine G. McGovern Medical School at UTHealth, Houston, TX (Klineberg).
J Am Acad Orthop Surg. 2024 Jul 15;32(14):627-636. doi: 10.5435/JAAOS-D-23-00778. Epub 2024 Apr 18.
Anterior cervical spine surgery (ACSS) is a surgical intervention widely used for a myriad of indications including degenerative, oncologic, inflammatory, traumatic, and congenital spinal conditions. A primary concern for surgeons performing ACSS is the postoperative development of oropharyngeal dysphagia. Current literature reports a wide incidence of this complication ranging from 1 to 79%. Dysphagia after ACSS is multifactorial, with common risk factors being prolonged duration of operation, revision surgeries, multilevel surgeries, and use of recombinant human bone morphogenetic protein-2. Many technical strategies have been developed to reduce the risk of postoperative dysphagia, including the development of low-profile implants and retropharyngeal local steroid application. In this article, we review the most recent literature regarding the epidemiology and pathophysiology, diagnostic criteria, risk factors, and management of dysphagia after ACSS.
颈椎前路手术(ACSS)是一种广泛应用于多种适应证的手术干预措施,包括退行性、肿瘤性、炎症性、创伤性和先天性脊柱疾病。进行 ACSS 的外科医生主要关注的是术后发生的咽困难。目前的文献报道,这种并发症的发生率很广,范围为 1%至 79%。ACSS 后吞咽困难是多因素的,常见的危险因素包括手术时间延长、翻修手术、多节段手术以及使用重组人骨形态发生蛋白-2。已经开发出许多技术策略来降低术后吞咽困难的风险,包括开发低轮廓植入物和咽后局部应用皮质类固醇。本文综述了有关 ACSS 后吞咽困难的流行病学和病理生理学、诊断标准、危险因素和处理的最新文献。